Exploring disparities in receipt of adjuvant chemotherapy in culturally and linguistically diverse groups: an Australian centre's experience

• DOI: 10.1111/imj.13572
• Publication Date: 2017-08-01T11:14:39Z
• Authors: Alesha A. Thai; Mark Tacey; Amanda Byrne; Shane White; Jaclyn Yoong
• Keywords: Adjuvant Chemotherapy; Receipt

Abstract Background Globally, racial and ethnic disparities exist in treatments outcomes for cancer patients. In Australia, there are few published data related to patients from culturally linguistically diverse ( CALD ) backgrounds. Aim To explore adjuvant chemotherapy utilisation groups. Methods Retrospective analysis of who were recommended early stage breast or colorectal between July 2011 October 2014 was performed. Rates uptake analysed those identified English as their first‐preferred language, versus did not, well born a country where is the main language (non‐ ), not ). Results Two hundred eleven identified. One forty‐three (67.7%) had 68 (32.2%) cancer. No difference detected acceptance non‐ (80.9%) (81.3%, P = 0.984) (80.8%) (81.8%, 0.870). There no rate completion, with 75.6% completion non‐English‐speaking group 81.1% English‐speaking 0.426). Conclusion observed compared This first study assess these differences Australia.